{"id":"https://openalex.org/W2093644875","doi":"https://doi.org/10.1097/00008877-200212000-00003","title":"Effects of dopamine receptor antagonists on nicotine-induced attentional enhancement","display_name":"Effects of dopamine receptor antagonists on nicotine-induced attentional enhancement","publication_year":2002,"publication_date":"2002-12-01","ids":{"openalex":"https://openalex.org/W2093644875","doi":"https://doi.org/10.1097/00008877-200212000-00003","mag":"2093644875","pmid":"https://pubmed.ncbi.nlm.nih.gov/12478212"},"language":"en","primary_location":{"id":"doi:10.1097/00008877-200212000-00003","doi":"https://doi.org/10.1097/00008877-200212000-00003","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008877-200212000-00003","pdf_url":null,"source":{"id":"https://openalex.org/S9181514","display_name":"Behavioural Pharmacology","issn_l":"0955-8810","issn":["0955-8810","1473-5849"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003080102","display_name":"Britta Hahn","orcid":"https://orcid.org/0000-0002-0709-4543","observed_orcids":["https://orcid.org/0000-0002-0709-4543"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"B. Hahn","raw_affiliation_strings":["Section of Behavioural Pharmacology, P049, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, UK. b.hahn@iop.kcl.ac.uk","Received 27 May 2002","Section of Behavioural Pharmacology, Institute of Psychiatry, King's College London, London, UK","accepted as revised 2 September 2002"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Behavioural Pharmacology, P049, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, UK. b.hahn@iop.kcl.ac.uk","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Received 27 May 2002","institution_ids":[]},{"raw_affiliation_string":"Section of Behavioural Pharmacology, Institute of Psychiatry, King's College London, London, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"accepted as revised 2 September 2002","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029172157","display_name":"M. Shoaib","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. Shoaib","raw_affiliation_strings":["Section of Behavioural Pharmacology, Institute of Psychiatry, King's College London, London, UK","to Britta Hahn, Section of Behavioural Pharmacology, P049, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, UK. E-mail: [email\u00a0protected]","Received 27 May 2002","accepted as revised 2 September 2002"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Behavioural Pharmacology, Institute of Psychiatry, King's College London, London, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"to Britta Hahn, Section of Behavioural Pharmacology, P049, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, UK. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"Received 27 May 2002","institution_ids":[]},{"raw_affiliation_string":"accepted as revised 2 September 2002","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059778310","display_name":"Ian P. Stolerman","orcid":"https://orcid.org/0000-0002-2703-5137","observed_orcids":["https://orcid.org/0000-0002-2703-5137"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"I.P. Stolerman","raw_affiliation_strings":["Received 27 May 2002","Section of Behavioural Pharmacology, Institute of Psychiatry, King's College London, London, UK","accepted as revised 2 September 2002"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Received 27 May 2002","institution_ids":[]},{"raw_affiliation_string":"Section of Behavioural Pharmacology, Institute of Psychiatry, King's College London, London, UK","institution_ids":["https://openalex.org/I183935753"]},{"raw_affiliation_string":"accepted as revised 2 September 2002","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5003080102"],"corresponding_institution_ids":["https://openalex.org/I183935753"],"apc_list":null,"apc_paid":null,"fwci":0.4647,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.55478329,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"13","issue":"8","first_page":"621","last_page":"632"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6083999872207642,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6083999872207642,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.35910001397132874,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10060","display_name":"Smoking Behavior and Cessation","score":0.011900000274181366,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nicotine","display_name":"nicotine","score":0.9279999732971191},{"id":"https://openalex.org/keywords/dopamine-receptors","display_name":"dopamine receptors","score":0.734000027179718},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.7549999952316284},{"id":"https://openalex.org/keywords/dopamine-d1-receptor","display_name":"dopamine D1 receptor","score":0.9980000257492065},{"id":"https://openalex.org/keywords/raclopride","display_name":"raclopride","score":0.9070000052452087},{"id":"https://openalex.org/keywords/sch-23390","display_name":"SCH 23390","score":0.9940000176429749},{"id":"https://openalex.org/keywords/attention-enhancement","display_name":"attentional enhancement","score":0.8460000157356262},{"id":"https://openalex.org/keywords/five-choice-serial-reaction-time-task","display_name":"5-choice serial reaction time task","score":0.9319999814033508},{"id":"https://openalex.org/keywords/response-latency","display_name":"response latency","score":0.7670000195503235},{"id":"https://openalex.org/keywords/omission-errors","display_name":"omission errors","score":0.8740000128746033},{"id":"https://openalex.org/keywords/nicotine-dependence","display_name":"nicotine dependence","score":0.5149999856948853}],"concepts":[{"id":"https://openalex.org/C2781069445","wikidata":"https://www.wikidata.org/wiki/Q7279814","display_name":"Raclopride","level":4,"score":0.9231970310211182},{"id":"https://openalex.org/C2779547902","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine","level":2,"score":0.8453691005706787},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6706961393356323},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6062605381011963},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.5892601013183594},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5071897506713867},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4849252998828888},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4813135862350464},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4675782024860382},{"id":"https://openalex.org/C120069818","wikidata":"https://www.wikidata.org/wiki/Q415496","display_name":"Dopamine receptor","level":3,"score":0.4387734532356262},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.42859140038490295},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4166496992111206},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.39031946659088135},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.33492332696914673},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2537708878517151}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001288","descriptor_name":"Attention","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001552","descriptor_name":"Benzazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002755","descriptor_name":"Choice Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009538","descriptor_name":"Nicotine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011597","descriptor_name":"Psychomotor Performance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011930","descriptor_name":"Reaction Time","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017447","descriptor_name":"Receptors, Dopamine D1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020891","descriptor_name":"Raclopride","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065127","descriptor_name":"Dopamine D2 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/00008877-200212000-00003","doi":"https://doi.org/10.1097/00008877-200212000-00003","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00008877-200212000-00003","pdf_url":null,"source":{"id":"https://openalex.org/S9181514","display_name":"Behavioural Pharmacology","issn_l":"0955-8810","issn":["0955-8810","1473-5849"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural Pharmacology","raw_type":"journal-article"},{"id":"pmid:12478212","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12478212","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioural pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:kclpure.kcl.ac.uk:publications/e4d0088a-101c-4551-bc4c-f04a5e063459","doi":null,"is_oa":false,"landing_page_url":"http://www.scopus.com/inward/record.url?scp=0036968687&partnerID=8YFLogxK","pdf_url":null,"source":{"id":"https://openalex.org/S4306400216","display_name":"Research Portal (King's College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I183935753","host_organization_name":"King's College London","host_organization_lineage":["https://openalex.org/I183935753"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hahn, B, Shoaib, M & Stolerman, I P 2002, 'Effects of dopamine receptor antagonists on nicotine-induced attentional enhancement', Behavioural Pharmacology, vol. 13, no. 8, pp. 621 - 632. https://doi.org/10.1097/01/fbp.0000046506.84018.28","raw_type":"info:eu-repo/semantics/publishedVersion"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.7099999785423279,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W1492673141","https://openalex.org/W1526007128","https://openalex.org/W1964386076","https://openalex.org/W1965424617","https://openalex.org/W1967092126","https://openalex.org/W1971270348","https://openalex.org/W1977947329","https://openalex.org/W1978812850","https://openalex.org/W1984039810","https://openalex.org/W1987440991","https://openalex.org/W1989291999","https://openalex.org/W2000363595","https://openalex.org/W2003873821","https://openalex.org/W2004618736","https://openalex.org/W2010375213","https://openalex.org/W2011246896","https://openalex.org/W2014663087","https://openalex.org/W2019707727","https://openalex.org/W2022151784","https://openalex.org/W2025739058","https://openalex.org/W2026015525","https://openalex.org/W2033047925","https://openalex.org/W2038423077","https://openalex.org/W2039110658","https://openalex.org/W2044831514","https://openalex.org/W2048488920","https://openalex.org/W2062990061","https://openalex.org/W2063180830","https://openalex.org/W2064409585","https://openalex.org/W2066245502","https://openalex.org/W2069541573","https://openalex.org/W2077760177","https://openalex.org/W2078656471","https://openalex.org/W2081391428","https://openalex.org/W2084024459","https://openalex.org/W2087576652","https://openalex.org/W2093053385","https://openalex.org/W2115005692","https://openalex.org/W2115275316","https://openalex.org/W2117518771","https://openalex.org/W2123133405","https://openalex.org/W2123268199","https://openalex.org/W2124407078","https://openalex.org/W2126893363","https://openalex.org/W2165398609","https://openalex.org/W2171654167","https://openalex.org/W2444051393","https://openalex.org/W4239785504"],"related_works":["https://openalex.org/W2016044279","https://openalex.org/W7222634010","https://openalex.org/W2070283278","https://openalex.org/W1977574107","https://openalex.org/W4412714524","https://openalex.org/W2076778820","https://openalex.org/W7222750354","https://openalex.org/W2022498670","https://openalex.org/W2080949180","https://openalex.org/W2063180830"],"abstract_inverted_index":{"An":[0],"understanding":[1],"of":[2,24,28,37,43,49,55,80,91,104,121,163,208,235],"the":[3,29,35,41,56,65,76,92,102,119,145,161,171,180,189,206,214,217],"neuropharmacological":[4],"mechanisms":[5],"mediating":[6],"attentional":[7,51],"enhancement":[8],"by":[9],"nicotine":[10,44,81,122,209,236],"would":[11],"indicate":[12,197],"whether":[13],"these":[14,241],"effects":[15,23,42,54,120,169,207,234,242],"could":[16],"be":[17,203,244],"dissociated":[18],"pharmacologically":[19,245],"from":[20],"other":[21],"behavioural":[22,233],"nicotine.":[25],"The":[26,53,195],"aim":[27],"present":[30],"study":[31],"was":[32,186],"to":[33,188],"examine":[34],"involvement":[36],"dopamine":[38,58,200,219],"neurotransmission":[39],"in":[40,74,84,87,148,179,192,205,225,237],"on":[45,123,157,210],"different":[46],"response":[47,112,149,211],"indices":[48],"an":[50],"paradigm.":[52],"D2-type":[57,199,218],"receptor":[59,67,220],"antagonist":[60,68,221],"raclopride":[61,115,128],"(0.025-0.1":[62],"mg/kg)":[63,71],"and":[64,78,110,125,131,183],"D1-type":[66],"SCH23390":[69,117,132],"(0.006-0.024":[70],"were":[72],"tested,":[73],"both":[75,165],"presence":[77,162],"absence":[79],"(0.1":[82],"mg/kg),":[83],"rats":[85],"trained":[86],"a":[88],"modified":[89],"version":[90],"five-choice":[93],"serial":[94],"reaction":[95],"time":[96],"task":[97],"(5-CSRTT).":[98],"Nicotine":[99],"robustly":[100],"enhanced":[101],"accuracy":[103,124,130],"signal":[105,226],"detection,":[106,227],"reduced":[107,177],"omission":[108],"errors":[109],"shortened":[111],"latencies.":[113],"Neither":[114,213],"nor":[116,216],"altered":[118],"omissions,":[126],"but":[127,141],"augmented":[129],"increased":[133],"omissions":[134],"when":[135],"given":[136],"alone.":[137],"By":[138],"contrast,":[139],"raclopride,":[140],"not":[142],"SCH23390,":[143],"reversed":[144,231],"nicotine-induced":[146,190,223],"reductions":[147],"latencies,":[150],"at":[151,170,228],"doses":[152,229],"that":[153,198,230],"had":[154,167],"no":[155],"effect":[156,185],"their":[158],"own.":[159],"In":[160],"nicotine,":[164],"antagonists":[166,175],"rate-disruptive":[168],"highest":[172],"dose.":[173],"Both":[174],"also":[176],"responding":[178],"intertrial":[181],"interval,":[182],"this":[184,193],"additive":[187],"decrease":[191],"measure.":[194],"data":[196],"receptors":[201],"may":[202,243],"involved":[204],"speed.":[212],"D1-":[215],"affected":[222],"improvements":[224],"dependence-related":[232],"previous":[238],"studies.":[239],"Thus":[240],"dissociable.":[246]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}